Viking Therapeutics (VKTX) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CAI International (CAI) Misses Q3 EPS by 11c ; Offers Guidance
- Curtiss-Wright (CW) Tops Q3 EPS by 17c; offers guidance
- Chime Financial, Inc. (CHYM) Tops Q3 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
